25.10
price up icon1.50%   0.37
after-market Dopo l'orario di chiusura: 24.96 -0.14 -0.56%
loading
Precedente Chiudi:
$24.73
Aprire:
$24.75
Volume 24 ore:
18.68M
Relative Volume:
1.97
Capitalizzazione di mercato:
$9.77B
Reddito:
$3.14B
Utile/perdita netta:
$-3.36B
Rapporto P/E:
-2.8751
EPS:
-8.73
Flusso di cassa netto:
$-4.03B
1 W Prestazione:
-6.66%
1M Prestazione:
-26.50%
6M Prestazione:
-19.27%
1 anno Prestazione:
-68.22%
Intervallo 1D:
Value
$24.28
$25.64
Intervallo di 1 settimana:
Value
$24.28
$27.80
Portata 52W:
Value
$23.15
$80.56

Moderna Inc Stock (MRNA) Company Profile

Name
Nome
Moderna Inc
Name
Telefono
(617) 714-6500
Name
Indirizzo
325 BINNEY STREET, CAMBRIDGE
Name
Dipendente
5,800
Name
Cinguettio
@moderna_tx
Name
Prossima data di guadagno
2025-08-01
Name
Ultimi documenti SEC
Name
MRNA's Discussions on Twitter

Confronta MRNA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MRNA
Moderna Inc
25.10 9.62B 3.14B -3.36B -4.03B -8.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
389.08 99.27B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
586.96 62.28B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.18 59.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
707.96 43.34B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
300.14 36.72B 3.81B -644.79M -669.77M -6.24

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato Citigroup Neutral
2025-02-18 Downgrade Barclays Overweight → Equal Weight
2025-01-29 Downgrade Goldman Buy → Neutral
2024-12-18 Downgrade Argus Buy → Hold
2024-12-10 Ripresa BofA Securities Underperform
2024-11-19 Iniziato Berenberg Hold
2024-11-18 Aggiornamento HSBC Securities Hold → Buy
2024-11-15 Iniziato Wolfe Research Underperform
2024-10-17 Iniziato Bernstein Mkt Perform
2024-09-13 Downgrade JP Morgan Neutral → Underweight
2024-09-13 Downgrade Jefferies Buy → Hold
2024-09-13 Downgrade Oppenheimer Outperform → Perform
2024-08-28 Aggiornamento HSBC Securities Reduce → Hold
2024-08-07 Aggiornamento Deutsche Bank Sell → Hold
2024-08-05 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Downgrade HSBC Securities Hold → Reduce
2024-01-02 Aggiornamento Oppenheimer Perform → Outperform
2023-11-29 Iniziato Canaccord Genuity Hold
2023-11-03 Aggiornamento HSBC Securities Reduce → Hold
2023-11-02 Downgrade Deutsche Bank Hold → Sell
2023-08-04 Downgrade TD Cowen Outperform → Market Perform
2023-08-03 Downgrade Deutsche Bank Buy → Hold
2023-07-24 Iniziato William Blair Mkt Perform
2023-07-14 Iniziato HSBC Securities Reduce
2023-06-26 Aggiornamento UBS Neutral → Buy
2023-04-26 Iniziato Guggenheim Neutral
2023-03-13 Aggiornamento TD Cowen Market Perform → Outperform
2023-03-02 Iniziato RBC Capital Mkts Outperform
2023-02-24 Downgrade SVB Securities Market Perform → Underperform
2022-12-19 Aggiornamento Jefferies Hold → Buy
2022-12-14 Downgrade Chardan Capital Markets Buy → Neutral
2022-10-21 Aggiornamento SVB Leerink Underperform → Mkt Perform
2022-09-08 Aggiornamento Deutsche Bank Hold → Buy
2022-02-01 Aggiornamento Redburn Sell → Neutral
2022-01-26 Aggiornamento Deutsche Bank Sell → Hold
2022-01-21 Aggiornamento BofA Securities Underperform → Neutral
2022-01-21 Iniziato UBS Neutral
2021-12-07 Iniziato Cowen Market Perform
2021-11-09 Iniziato Wolfe Research Outperform
2021-10-22 Iniziato Deutsche Bank Sell
2021-10-15 Aggiornamento Piper Sandler Neutral → Overweight
2021-08-06 Downgrade Oppenheimer Outperform → Perform
2021-08-06 Downgrade Piper Sandler Overweight → Neutral
2021-07-15 Reiterato Jefferies Hold
2021-02-01 Downgrade BofA Securities Neutral → Underperform
2020-12-16 Downgrade Jefferies Buy → Hold
2020-12-16 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-12-09 Downgrade Needham Buy → Hold
2020-11-23 Iniziato Wells Fargo Equal Weight
2020-11-17 Downgrade BMO Capital Markets Outperform → Market Perform
2020-09-08 Downgrade SVB Leerink Mkt Perform → Underperform
2020-07-23 Iniziato SVB Leerink Mkt Perform
2020-07-20 Downgrade JP Morgan Overweight → Neutral
2020-07-13 Iniziato Jefferies Buy
2020-06-30 Iniziato Argus Buy
2020-06-08 Iniziato Barclays Overweight
2020-04-30 Iniziato BMO Capital Markets Outperform
2020-03-05 Downgrade BofA/Merrill Buy → Neutral
2019-12-03 Ripresa BofA/Merrill Buy
2019-10-25 Iniziato ROTH Capital Buy
2019-04-05 Iniziato Chardan Capital Markets Buy
Mostra tutto

Moderna Inc Borsa (MRNA) Ultime notizie

pulisher
Aug 27, 2025

Comparing Moderna Inc. in custom built stock radarsMarket Movers & High Accuracy Buy Signal Tips - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Hsbc Holdings PLC Has $17.91 Million Holdings in Moderna, Inc. $MRNA - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Jump Financial LLC Has $25.58 Million Stock Position in Moderna, Inc. $MRNA - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Wellington Management Group LLP Cuts Stake in Moderna, Inc. $MRNA - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Moderna, Inc. $MRNA Shares Sold by Russell Investments Group Ltd. - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Cresset Asset Management LLC Buys Shares of 18,420 Moderna, Inc. $MRNA - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Aberdeen Group plc Decreases Position in Moderna, Inc. $MRNA - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Credit Agricole S A Decreases Position in Moderna, Inc. $MRNA - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Candriam S.C.A. Decreases Position in Moderna, Inc. $MRNA - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Korea Investment CORP Boosts Stake in Moderna, Inc. $MRNA - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

FDA approves COVID-19 vaccines only for ‘high risk’ people - Yahoo News Australia

Aug 27, 2025
pulisher
Aug 27, 2025

Which COVID-19 vaccines are FDA approved in US? - Reuters

Aug 27, 2025
pulisher
Aug 27, 2025

FDA Curbs Covid Shot Access as RFK Jr. Takes Tougher Stance - Bloomberg.com

Aug 27, 2025
pulisher
Aug 27, 2025

Moderna to Present at Upcoming Conferences in September 2025 - Canton Repository

Aug 27, 2025
pulisher
Aug 27, 2025

RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines - Benzinga

Aug 27, 2025
pulisher
Aug 27, 2025

FDA approves updated COVID boosters, but narrows use - BioPharma Dive

Aug 27, 2025
pulisher
Aug 27, 2025

Why Moderna (MRNA) Stock Is Up Today - TradingView

Aug 27, 2025
pulisher
Aug 27, 2025

Moderna Receives US FDA Approval for Updated COVID-19 Vaccines Targeting the LP.8.1 Variant - MarketScreener

Aug 27, 2025
pulisher
Aug 27, 2025

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 - The Joplin Globe

Aug 27, 2025
pulisher
Aug 27, 2025

Latest COVID Defense: Moderna's New LP.8.1 Vaccines Cover 4M Annual Cases, FDA Gives Green Light - Stock Titan

Aug 27, 2025
pulisher
Aug 27, 2025

FDA approves updated Covid vaccines, including mRNA shots from Pfizer, Moderna - Endpoints News

Aug 27, 2025
pulisher
Aug 27, 2025

FDA authorizes updated Covid-19 shots, but with restrictions - Seeking Alpha

Aug 27, 2025
pulisher
Aug 27, 2025

F.D.A. Approves Covid Shots With New Restrictions - The New York Times

Aug 27, 2025
pulisher
Aug 27, 2025

Moderna (NASDAQ:MRNA) Stock Price Down 5.2% Following Analyst Downgrade - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Moderna Challenged on Bid to Shift Covid-Shot Patent Costs to US - Bloomberg Law News

Aug 27, 2025
pulisher
Aug 27, 2025

Stock Analysis | Moderna OutlookA Deep Dive Into Mixed Signals and Key Catalysts - AInvest

Aug 27, 2025
pulisher
Aug 27, 2025

Moderna, Inc. $MRNA Shares Sold by Groupe la Francaise - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Moderna, Inc. $MRNA Shares Bought by Northern Trust Corp - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Moderna, Inc. $MRNA Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Banco Bilbao Vizcaya Argentaria S.A. Sells 183,308 Shares of Moderna, Inc. $MRNA - MarketBeat

Aug 27, 2025
pulisher
Aug 27, 2025

Developing predictive dashboards with Moderna Inc. dataMarket Volume Report & AI Optimized Trading Strategy Guides - Newser

Aug 27, 2025
pulisher
Aug 26, 2025

UK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTech - Corpus Christi Caller-Times

Aug 26, 2025
pulisher
Aug 26, 2025

Short interest data insights for Moderna Inc.July 2025 Opening Moves & Entry and Exit Point Strategies - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Will breakout in Moderna Inc. lead to full recovery2025 Support & Resistance & Growth Focused Investment Plans - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Moderna Inc. stock retracement – recovery analysis2025 Trading Recap & Intraday High Probability Setup Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Moderna, Inc. shares fall 2.37% intraday amid political uncertainty and Fed independence concerns. - AInvest

Aug 26, 2025
pulisher
Aug 26, 2025

Market reaction to Moderna Inc.’s recent newsDollar Strength & Long-Term Growth Portfolio Plans - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Untreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight - GlobeNewswire Inc.

Aug 26, 2025
pulisher
Aug 26, 2025

Using RSI to spot recovery in Moderna Inc.July 2025 Opening Moves & Pattern Based Trade Signal System - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Moderna stock falls, Pfizer dips on COVID vaccine ban speculation - Investing.com

Aug 26, 2025
pulisher
Aug 25, 2025

Contra Guys: This revolutionary biotech pioneer has joined our watchlist - The Globe and Mail

Aug 25, 2025
pulisher
Aug 25, 2025

Moderna Inc. stock momentum explainedRisk Management & Free High Accuracy Swing Entry Alerts - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

What’s the recovery path for long term holders of Moderna Inc.2025 Macro Impact & Low Risk Entry Point Tips - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' - Benzinga

Aug 25, 2025
pulisher
Aug 25, 2025

Trump administration could ban COVID-19 jabs 'within months': Daily Beast (MRNA:NASDAQ) - Seeking Alpha

Aug 25, 2025
pulisher
Aug 25, 2025

Covid vaccine critic tapped to lead CDC advisory committee on shots - Seeking Alpha

Aug 25, 2025
pulisher
Aug 25, 2025

Moderna’s updated Covid-19 vaccine gets Canadian approval - Yahoo Finance

Aug 25, 2025
pulisher
Aug 25, 2025

Northwest & Ethical Investments L.P. Sells 21,004 Shares of Moderna, Inc. $MRNA - MarketBeat

Aug 25, 2025
pulisher
Aug 24, 2025

Moderna, Inc. $MRNA Shares Purchased by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat

Aug 24, 2025
pulisher
Aug 24, 2025

Moderna, Inc. (NASDAQ:MRNA) Receives $43.59 Average Target Price from Analysts - MarketBeat

Aug 24, 2025
pulisher
Aug 24, 2025

Moderna, Inc. (MRNA) Down 35% YTD. Here Is Why - MSN

Aug 24, 2025

Moderna Inc Azioni (MRNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):